US Stock MarketDetailed Quotes

AGIO Agios Pharmaceuticals

Watchlist
  • 38.965
  • +0.795+2.08%
Close Dec 13 16:00 ET
  • 38.960
  • -0.005-0.01%
Post 20:01 ET
2.22BMarket Cap3.34P/E (TTM)

Agios Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
21.15%8.96M
28.35%8.62M
46.00%8.19M
88.36%26.82M
64.80%7.1M
110.44%7.4M
20.24%6.71M
574.16%5.61M
14.24M
4.31M
Operating revenue
21.15%8.96M
28.35%8.62M
46.00%8.19M
88.36%26.82M
64.80%7.1M
110.44%7.4M
20.24%6.71M
574.16%5.61M
--14.24M
--4.31M
Cost of revenue
23.70%783K
34.93%1.5M
13.18%627K
69.07%2.88M
41.89%586K
22.44%633K
154.71%1.11M
63.42%554K
1.7M
413K
Gross profit
20.91%8.18M
27.05%7.12M
49.59%7.56M
90.99%23.94M
67.23%6.52M
125.61%6.77M
8.88%5.6M
925.35%5.06M
12.54M
3.9M
Operating expense
3.09%110.99M
13.73%112.94M
4.15%99.63M
3.45%415.43M
9.44%112.79M
14.43%107.66M
-3.39%99.3M
-5.87%95.67M
6.12%401.58M
-1.68%103.07M
Selling and administrative expenses
49.24%38.54M
16.86%35.54M
9.33%31.01M
-1.45%119.9M
7.73%35.31M
-11.33%25.82M
7.59%30.41M
-9.99%28.37M
0.19%121.67M
3.94%32.77M
Research and development costs
-11.47%72.46M
12.35%77.4M
1.96%68.62M
5.58%295.53M
10.23%77.49M
25.98%81.84M
-7.55%68.9M
-4.02%67.3M
8.93%279.91M
-4.09%70.3M
Operating profit
-1.90%-102.81M
-12.93%-105.82M
-1.61%-92.07M
-0.63%-391.49M
-7.16%-106.28M
-10.77%-100.9M
4.04%-93.7M
10.41%-90.61M
-2.81%-389.05M
5.39%-99.17M
Net non-operating interest income expense
55.93%13.06M
-1.62%8.12M
9.86%8.89M
160.64%33.34M
32.92%8.62M
119.36%8.38M
360.35%8.25M
1,065.85%8.09M
1,430.26%12.79M
1,854.22%6.49M
Non-operating interest income
55.93%13.06M
-1.62%8.12M
9.86%8.89M
160.64%33.34M
32.92%8.62M
119.36%8.38M
360.35%8.25M
1,065.85%8.09M
1,430.26%12.79M
1,854.22%6.49M
Other net income (expense)
90,950.67%1.09B
-3.72%1.58M
8.64%1.63M
-95.81%6.06M
-98.67%1.71M
-78.32%1.2M
-59.42%1.64M
-73.51%1.5M
585.52%144.45M
2,085.92%129.21M
Special income (charges)
--1.09B
----
----
--0
--0
--0
----
----
1,974.17%137.7M
4,737.42%127.85M
-Gain on sale of business
--1.09B
----
----
--0
--0
--0
----
----
1,974.17%137.7M
4,737.42%127.85M
Other non- operating income (expenses)
37.81%1.65M
-3.72%1.58M
8.64%1.63M
-10.28%6.06M
26.23%1.71M
10.72%1.2M
22.66%1.64M
-49.41%1.5M
-53.24%6.75M
-58.48%1.36M
Income before tax
1,196.14%1B
-14.69%-96.12M
-0.66%-81.55M
-51.89%-352.09M
-362.66%-95.94M
-11.72%-91.32M
8.71%-83.81M
14.51%-81.02M
34.98%-231.8M
137.05%36.53M
Income tax
53.12M
0
Net income
1,137.97%947.92M
-14.69%-96.12M
-0.66%-81.55M
-51.89%-352.09M
-362.66%-95.94M
-11.72%-91.32M
8.71%-83.81M
14.51%-81.02M
-114.44%-231.8M
138.60%36.53M
Net income continuous Operations
1,137.97%947.92M
-14.69%-96.12M
-0.66%-81.55M
-51.89%-352.09M
-362.66%-95.94M
-11.72%-91.32M
8.71%-83.81M
14.51%-81.02M
34.98%-231.8M
137.05%36.53M
Net income discontinuous operations
----
----
----
--0
----
----
----
----
--0
----
Minority interest income
Net income attributable to the parent company
1,137.97%947.92M
-14.69%-96.12M
-0.66%-81.55M
-51.89%-352.09M
-362.66%-95.94M
-11.72%-91.32M
8.71%-83.81M
14.51%-81.02M
-114.44%-231.8M
138.60%36.53M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
1,137.97%947.92M
-14.69%-96.12M
-0.66%-81.55M
-51.89%-352.09M
-362.66%-95.94M
-11.72%-91.32M
8.71%-83.81M
14.51%-81.02M
-114.44%-231.8M
138.60%36.53M
Basic earnings per share
1,115.24%16.65
-11.92%-1.69
1.36%-1.45
-49.65%-6.33
-356.72%-1.72
-10.07%-1.64
10.12%-1.51
15.52%-1.47
-115.93%-4.23
138.51%0.67
Diluted earnings per share
1,089.02%16.22
-11.92%-1.69
1.36%-1.45
-49.65%-6.33
-356.72%-1.72
-10.07%-1.64
10.12%-1.51
15.52%-1.47
-115.93%-4.23
138.51%0.67
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 21.15%8.96M28.35%8.62M46.00%8.19M88.36%26.82M64.80%7.1M110.44%7.4M20.24%6.71M574.16%5.61M14.24M4.31M
Operating revenue 21.15%8.96M28.35%8.62M46.00%8.19M88.36%26.82M64.80%7.1M110.44%7.4M20.24%6.71M574.16%5.61M--14.24M--4.31M
Cost of revenue 23.70%783K34.93%1.5M13.18%627K69.07%2.88M41.89%586K22.44%633K154.71%1.11M63.42%554K1.7M413K
Gross profit 20.91%8.18M27.05%7.12M49.59%7.56M90.99%23.94M67.23%6.52M125.61%6.77M8.88%5.6M925.35%5.06M12.54M3.9M
Operating expense 3.09%110.99M13.73%112.94M4.15%99.63M3.45%415.43M9.44%112.79M14.43%107.66M-3.39%99.3M-5.87%95.67M6.12%401.58M-1.68%103.07M
Selling and administrative expenses 49.24%38.54M16.86%35.54M9.33%31.01M-1.45%119.9M7.73%35.31M-11.33%25.82M7.59%30.41M-9.99%28.37M0.19%121.67M3.94%32.77M
Research and development costs -11.47%72.46M12.35%77.4M1.96%68.62M5.58%295.53M10.23%77.49M25.98%81.84M-7.55%68.9M-4.02%67.3M8.93%279.91M-4.09%70.3M
Operating profit -1.90%-102.81M-12.93%-105.82M-1.61%-92.07M-0.63%-391.49M-7.16%-106.28M-10.77%-100.9M4.04%-93.7M10.41%-90.61M-2.81%-389.05M5.39%-99.17M
Net non-operating interest income expense 55.93%13.06M-1.62%8.12M9.86%8.89M160.64%33.34M32.92%8.62M119.36%8.38M360.35%8.25M1,065.85%8.09M1,430.26%12.79M1,854.22%6.49M
Non-operating interest income 55.93%13.06M-1.62%8.12M9.86%8.89M160.64%33.34M32.92%8.62M119.36%8.38M360.35%8.25M1,065.85%8.09M1,430.26%12.79M1,854.22%6.49M
Other net income (expense) 90,950.67%1.09B-3.72%1.58M8.64%1.63M-95.81%6.06M-98.67%1.71M-78.32%1.2M-59.42%1.64M-73.51%1.5M585.52%144.45M2,085.92%129.21M
Special income (charges) --1.09B----------0--0--0--------1,974.17%137.7M4,737.42%127.85M
-Gain on sale of business --1.09B----------0--0--0--------1,974.17%137.7M4,737.42%127.85M
Other non- operating income (expenses) 37.81%1.65M-3.72%1.58M8.64%1.63M-10.28%6.06M26.23%1.71M10.72%1.2M22.66%1.64M-49.41%1.5M-53.24%6.75M-58.48%1.36M
Income before tax 1,196.14%1B-14.69%-96.12M-0.66%-81.55M-51.89%-352.09M-362.66%-95.94M-11.72%-91.32M8.71%-83.81M14.51%-81.02M34.98%-231.8M137.05%36.53M
Income tax 53.12M0
Net income 1,137.97%947.92M-14.69%-96.12M-0.66%-81.55M-51.89%-352.09M-362.66%-95.94M-11.72%-91.32M8.71%-83.81M14.51%-81.02M-114.44%-231.8M138.60%36.53M
Net income continuous Operations 1,137.97%947.92M-14.69%-96.12M-0.66%-81.55M-51.89%-352.09M-362.66%-95.94M-11.72%-91.32M8.71%-83.81M14.51%-81.02M34.98%-231.8M137.05%36.53M
Net income discontinuous operations --------------0------------------0----
Minority interest income
Net income attributable to the parent company 1,137.97%947.92M-14.69%-96.12M-0.66%-81.55M-51.89%-352.09M-362.66%-95.94M-11.72%-91.32M8.71%-83.81M14.51%-81.02M-114.44%-231.8M138.60%36.53M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 1,137.97%947.92M-14.69%-96.12M-0.66%-81.55M-51.89%-352.09M-362.66%-95.94M-11.72%-91.32M8.71%-83.81M14.51%-81.02M-114.44%-231.8M138.60%36.53M
Basic earnings per share 1,115.24%16.65-11.92%-1.691.36%-1.45-49.65%-6.33-356.72%-1.72-10.07%-1.6410.12%-1.5115.52%-1.47-115.93%-4.23138.51%0.67
Diluted earnings per share 1,089.02%16.22-11.92%-1.691.36%-1.45-49.65%-6.33-356.72%-1.72-10.07%-1.6410.12%-1.5115.52%-1.47-115.93%-4.23138.51%0.67
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data